pre-update Archives

Announcement

Ghent University wins the 2021/22 Certara-Simcyp Grant and Partnership Scheme

PRINCETON, N.J., 2023 年 1 月 9 日 — Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation,…

Certara2023 年 1 月 9 日

Press Release

Certara 收购了 Vyasa，这是一家提供预测服务，以加速科学创新的人工智能公司

Certara improves software capabilities by expanding into deep learning and data fabric PRINCETON, N.J.— January…

Certara2023 年 1 月 4 日

White Paper

Drug interactions with therapeutic proteins, regulatory expectations and modeling and simulation approaches

Certara2023 年 1 月 3 日

Blog

New FDA Requirement to Support Labeling on DDIs in the Pediatric Population

The effects of drug-drug interactions (DDIs) could differ in the pediatric population compared to adults.…

Certara2022 年 12 月 21 日

Blog

The Phoenix Workflow Shortcuts Every Pharmacokineticist Needs

Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform can revolutionize your pharmaceutical organization’s approach to PK/PD…

Certara2022 年 12 月 16 日

Press Release

Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors

Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private Equity…

Certara2022 年 12 月 8 日

On-Demand Webinar

治疗蛋白质的药物间相互作用：最新情况与挑战

Therapeutic proteins (TP) - and more specifically monoclonal antibodies - are part of the therapeutic…

Certara2022 年 12 月 5 日

Brochure

BaseCase Portal

Certara2022 年 11 月 30 日

Article

Project Optimus: How to Prepare for Success

For some time now, cancer drug developers have known “Project Optimus” and new dose optimization…

Certara2022 年 11 月 28 日

White Paper

eCTD 提交流程：助力药物开发成功的技巧与诀窍

Our experts compiled the tips and best practices you need to know for a successful…

Certara2022 年 11 月 22 日

pre-update